Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly (NY: LLY ) 884.48 -1.46 (-0.16%) Official Closing Price Updated: 7:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,455,234 Open 888.83 Bid (Size) 881.40 (1) Ask (Size) 883.37 (2) Prev. Close 885.94 Today's Range 878.87 - 891.27 52wk Range 516.57 - 972.53 Shares Outstanding N/A Dividend Yield 0.51% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next Today 14:51 EDT HHS announced lower costs for 54 Medicare Part B drugs starting in October 2024, part of the Inflation Reduction Act's rebate program, which aims to curb rising drug prices and reduce out-of-pocket... Via Benzinga Topics Economy Exposures Interest Rates Eli Lilly's Options: A Look at What the Big Money is Thinking Today 11:01 EDT Via Benzinga Performance YTD +49.35% +49.35% 1 Month -7.53% -7.53% 3 Month -2.45% -2.45% 6 Month +15.78% +15.78% 1 Year +64.31% +64.31% More News Read More Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition Today 10:05 EDT Via Investor Brand Network Eli Lilly Eyes New Trials For Weight-Loss Drugs In Non-Obese Patients Today 9:36 EDT Via Benzinga Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points September 30, 2024 Via Benzinga Is NYSE:LLY a Fit for high Growth Investing Strategies? September 26, 2024 Via Chartmill Eli Lilly Unusual Options Activity September 25, 2024 Via Benzinga Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight Today 8:51 EDT Via Benzinga Transforming Alzheimer’s Treatment: Innovative Combinations to Boost Cognition Today 8:30 EDT Via FinancialNewsMedia Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate September 30, 2024 Via Benzinga Exposures Product Safety Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential September 30, 2024 Via Benzinga This Is the Best Pharma Stock to Invest $1,000 in Right Now September 29, 2024 Via The Motley Fool Eli Lilly And Co DCF Valuation: Is The Stock Undervalued? September 29, 2024 Via Talk Markets Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years September 28, 2024 Via The Motley Fool 1 Unstoppable Growth Stock Heading to $2 Trillion by 2030 September 28, 2024 Via The Motley Fool Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever September 28, 2024 Via The Motley Fool Stocks To Buy And Hold For 5 Years September 27, 2024 Via Talk Markets Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason September 27, 2024 Via The Motley Fool BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rallies 28% On Upsized IPO September 26, 2024 Via Investor's Business Daily Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why. September 26, 2024 Via The Motley Fool Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments September 25, 2024 Via Benzinga Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users September 25, 2024 Via Benzinga Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes September 25, 2024 Via Benzinga Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs September 25, 2024 Via Benzinga Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years September 25, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.